UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | M | O | P | R | S | T | Y
Number of items: 94.

A

Anderson, VM; Altmann, DR; Fisniku, L; Fox, NC; Miller, DH; (2007) Effects of an MRI scanner upgrade on longitudinal measures of brain atrophy and application of a statistical correction method. In: MULTIPLE SCLEROSIS. (pp. S179 - S179). SAGE PUBLICATIONS LTD

Anderson, VM; Bartlett, JW; Fox, NC; Fisniku, L; Miller, DH; (2007) Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: Sample size estimates. J NEUROL , 254 (11) 1588 - 1594. 10.1007/s00415-007-0599-3.

Anderson, VM; Fernando, KTM; Davies, GR; Rashid, W; Frost, C; Fox, NC; (2007) Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: A comparison of registration-based methods. J NEUROIMAGING , 17 (1) 61 - 68. 10.1111/j.1552-6569.2006.00081.x.

Anderson, VM; Fisniku, L; Fox, NC; Miller, D; (2007) A comparison of atrophy rates in multiple sclerosis measured by SIENA from 2D and 3D MR acquisitions. In: MULTIPLE SCLEROSIS. (pp. S178 - S178). SAGE PUBLICATIONS LTD

Audoin, B; Davies, G; Rashid, W; Fisniku, L; Thompson, AJ; Miller, DH; (2007) Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis. MULT SCLER , 13 (4) 483 - 489. 10.1177/1352458506070450.

B

Balcer, LJ; Galetta, SL; Calabresi, PA; Confavreux, C; Giovannoni, G; Havrdova, E; ... SENTINEL Investigators,; + view all (2007) Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. NEUROLOGY , 68 (16) 1299 - 1304.

Barkhof, F; Polman, CH; Radue, EW; Kappos, L; Freedman, MS; Edan, G; ... Sandbrink, R; + view all (2007) Magnetic resonance Imaging effects of interferon beta-1b in the BENEFIT study - Integrated 2-year results. ARCH NEUROL-CHICAGO , 64 (9) 1292 - 1298.

Benedict, RHB; Duquin, A; Jurgensen, S; Feichter, J; Goodman, A; Kappos, L; ... Weinstock-Guttman, B; + view all (2007) Monthly screening for neuropsychological impairment in multiple sclerosis. In: MULTIPLE SCLEROSIS JOURNAL. (pp. S236 - S236). SAGE PUBLICATIONS LTD

Black, JA; Newcombe, J; Trapp, BD; Waxman, SG; (2007) Sodium channel expression within chronic multiple sclerosis plaques. J NEUROPATH EXP NEUR , 66 (9) 828 - 837.

Bodini, B; Cercignani, M; Wheeler-Kingshott, C; Miller, DH; Thompson, AJ; Ciccarelli, O; (2007) Localised damage in normal appearing white matter of early PPMS contributes to disability: a tract-based spatial statistics study. In: MULTIPLE SCLEROSIS. (pp. S189 - S189). SAGE PUBLICATIONS LTD

C

Calabresi, PA; Giovannoni, G; Confavreux, C; Galetta, SL; Havrdova, E; Hutchinson, M; ... SENTINEL Investigators,; + view all (2007) The incidence and significance of anti-natalizumab antibodies - Results from AFFIRM and SENTINEL. NEUROLOGY , 69 (14) 1391 - 1403.

Chapman, MD; Thompson, EJ; Candler, PM; Dale, RC; Church, AJ; Giovannoni, G; (2007) Quantitative demonstration of intrathecal synthesis of high affinity immunoglobulin G in herpes simplex encephalitis using affinity-mediated immunoblotting. J NEUROIMMUNOL , 185 (1-2) 130 - 135. 10.1016/j.jneuroim.2007.01.002.

Chokkalingam, K; Tsintzas, K; Snaar, JEM; Norton, L; Solanky, B; Leverton, E; ... Macdonald, IA; + view all (2007) Hyperinsulinaemia during exercise does not suppress hepatic glycogen concentrations in patients with type 1 diabetes: a magnetic resonance spectroscopy study. DIABETOLOGIA , 50 (9) 1921 - 1929. 10.1007/s00125-007-0747-4.

Ciccarelli, O; Wheeler-Kingshott, C; McLean, M; Wimpley, K; Cercignani, M; Miller, DH; Thompson, AJ; (2007) Spinal cord diffusion imaging and spectroscopy to assess the impact of acute lesions in multiple sclerosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1024 - 1024). B M J PUBLISHING GROUP

Ciccarelli, O; Wheeler-Kingshott, CA; McLean, MA; Cercignani, M; Wimpey, K; Miller, DH; Thompson, AJ; (2007) Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. BRAIN , 130 2220 - 2231. 10.1093/brain/awm152.

Ciccarelli, O; Wheeler-Kingshott, CA; McLean, MA; Wimpey, K; Cercignani, M; Miller, DH; Thompson, AI; (2007) Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S190 - S190). SAGE PUBLICATIONS LTD

Coelho, A; Ceranic, B; Prasher, D; Miller, DH; Luxon, LM; (2007) Auditory efferent function is affected in multiple sclerosis. EAR HEARING , 28 (5) 593 - 604.

D

Davies, AL; Hayes, KC; Dekaban, GA; (2007) Clinical Correlates of Elevated Serum Concentrations of Cytokines and Autoantibodies in Patients With Spinal Cord Injury. Archives of Physical Medicine and Rehabilitation , 88 (11) 1384 - 1393. 10.1016/j.apmr.2007.08.004.

Davies, GR; Hadjiprocopis, A; Altmann, DR; Chard, DT; Griffin, CM; Rashid, W; ... Miller, DH; + view all (2007) Normal-appearing grey and white matter T-1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study. MULT SCLER , 13 (2) 169 - 177. 10.1177/1352458506070726.

De Stefano, N; Filippi, M; Miller, D; Pouwels, PJ; Rovira, A; Gass, A; ... Arnold, DL; + view all (2007) Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. NEUROLOGY , 69 (20) 1942 - 1952.

E

Ebringer, A; Rashid, T; Jawad, N; Wilson, C; Thompson, EJ; Ettelaie, C; (2007) From rabies to transmissible spongiform encephalopathies: An immune-mediated microbial trigger involving molecular mimicry could be the answer. Medical Hypotheses , 68 (1) 113 - 124. 10.1016/j.mehy.2006.06.017.

F

Farrell, R; Leary, S; Kapoor, R; Rudge, P; Thompson, AJ; Miller, DH; Giovannoni, G; (2007) Evaluation of anti-interferon beta antibodies in subjects with multiple sclerosis attending the national hospital for neurology and neurosurgery, London. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1038 - 1038). B M J PUBLISHING GROUP

Farrell, R; Leary, S; Kapoor, R; Rudge, P; Thompson, AJ; Miller, DH; Giovannoni, G; (2007) Neutralising antibodies to interferon beta are associated with loss of efficacy of treatment and reduced side effects. In: MULTIPLE SCLEROSIS. (pp. S59 - S59). SAGE PUBLICATIONS LTD

Fisher, E; Rudick, R; Dalton, CM; MacManus, D; Miller, DH; Lucas, N; ... Panzara, M; + view all (2007) The kinetics of brain atrophy during the first year of treatment with natalizumab. In: MULTIPLE SCLEROSIS. (pp. S168 - S168). SAGE PUBLICATIONS LTD

Fisniku, L; Gutierrez, L; Swanton, J; Altmann, DR; Miszkiel, KA; Thompson, AJ; Miller, DH; (2007) Ventricular volume in a cohort of clinically isolated syndrome patients followed up 20 years after the onset of disease. In: MULTIPLE SCLEROSIS. (pp. S179 - S179). SAGE PUBLICATIONS LTD

Fisniku, LK; Brex, PA; Miszkiel, K; Altmann, DR; Thompson, AJ; Miller, DH; (2007) Disability and T2 MRI abnormalities: A 20 year follow-up of patients with relapse onset of multiple sclerosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1015 - 1015). B M J PUBLISHING GROUP

Focke, N; Symms, MR; Samson, R; Duncan, JS; (2007) Voxel-based analysis of whole brain flair at 3T detects focal cortical dysplasia. In: EPILEPSIA. (pp. 155 - 155). BLACKWELL PUBLISHING

Frohman, EM; Stuve, O; Miller, DH; (2007) W. Ian McDonald, MB, ChB, PhD (1933-2006): the multiple sclerosis physician-scientist of the 20th century. Archives of Neurology , 64 (3) 452 - 454. 10.1001/archneur.64.3.452.

Fry, VA; Heales, SJ; Pocock, JM; (2007) The highs and lows of microglial glutathione. In: (Proceedings) Society for Neuroscience Annual Meeting. (pp. 804.19 - ?). Society for Neuroscience

Furby, J; Hayton, T; Smith, KJ; Altmann, DR; Brenner, R; Chataway, J; ... Kapoor, R; + view all (2007) The correlation between MR measures of atrophy and disability in secondary progressive multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S186 - S187). SAGE PUBLICATIONS LTD

G

Giovannoni, G; O'Connor, PW; Havrdova, E; Hutchinson, M; Kappos, L; Miller, DH; ... AFFIRM Investigators,; + view all (2007) The immunogenicity of natalizumab in patients with multiple sclerosis: Results from the AFFIRM study. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 208 - 208). B M J PUBLISHING GROUP

Gold, R; Jawad, A; Miller, DH; Henderson, DC; Fassas, A; Fierz, W; Hartung, HP; (2007) Expert opinion: Guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies. Journal of Neuroimmunology , 187 (1-2) 156 - 158. 10.1016/j.jneuroim.2007.04.006.

Gold, R; Jawad, A; Miller, DH; Henderson, DC; Fassas, A; Fierz, W; Hartung, HP; (2007) Expert opinion: Guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies. J NEUROIMMUNOL , 187 (1-2) 156 - 158. 10.1016/j.jneuroimi.2007.04.006.

Gorgoraptis, N; Wheelet-Kingshott, C; Jenkins, T; Miller, DH; Thompson, AJ; Ciccarelli, O; (2007) A probabilistic tractography study of the cortico-spinal tract in patients with multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S189 - S189). SAGE PUBLICATIONS LTD

H

Hartung, HP; Kappos, L; Polman, C; Edan, G; Freedman, MS; Miller, D; ... Sandbrink, R; + view all (2007) Betaferon (R)/betaseron (R) in newly emerging multiple sclerosis for initial treatment (benefit): Effects of early vs. delayed treatment with interferon beta-1B. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 20 - 20). BLACKWELL PUBLISHING

Havrdova, E; Giovannoni, G; Hutchinson, M; Kappos, L; Lublin, F; Miller, DH; ... Panzara, M; + view all (2007) Natalizumab increases the proportion of patients with multiple sclerosis who are disease-free. In: MULTIPLE SCLEROSIS. (pp. S170 - S170). SAGE PUBLICATIONS LTD

Hayes, KC; Davies, AL; Ashki, N; Kramer, JK; Close, TE; (2007) Re: Ditunno JF, Little JW, Tessler A, Burns AS. Spinal shock revisited: A four-phase model. Spinal Cord 2004; 42: 383-395 [2]. Spinal Cord , 45 (5) 395 - 396. 10.1038/sj.sc.3101981.

Herbert, J; Kappos, L; Giovannoni, G; Havrdova, E; Hutchinson, M; Lublin, F; ... Panzara, M; + view all (2007) Impact of natalizumab on multiple sclerosis severity: analysis of patients and subgroups from the AFFIRM study using the Multiple Sclerosis Severity Scale. In: MULTIPLE SCLEROSIS. (pp. S169 - S170). SAGE PUBLICATIONS LTD

Hooper, C; Pocock, JM; (2007) Chromogranin A activates diverse pathways mediating inducible nitric oxide expression and apoptosis in primary microglia. NEUROSCI LETT , 413 (3) 227 - 232. 10.1016/j.neulet.2006.11.068.

J

Jasperse, B; Valsasina, P; Neacsu, V; Knol, DL; De Stefano, N; Enzinger, C; ... Magnetic Imaging Multiple Sclerosi,; + view all (2007) Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX. J MAGN RESON IMAGING , 26 (4) 881 - 885. 10.1002/jmri.21101.

K

Kappos, L; Bates, D; Hartung, HP; Havrdova, E; Miller, D; Polman, CH; ... Clifford, DB; + view all (2007) Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. LANCET NEUROL , 6 (5) 431 - 441. 10.1016/S1474-4422(07)70078-9.

Kappos, L; Edan, G; Freedman, M; Hartung, HP; Miller, D; Montalban, X; ... Sandbrink, R; + view all (2007) The BENEFIT study: characteristics of patients with potentially benign multiple sclerosis. In: JOURNAL OF NEUROLOGY. (pp. 191 - 192). DR DIETRICH STEINKOPFF VERLAG

Kappos, L; Freedman, MS; Polman, CH; Edan, G; Hartung, HP; Miller, DH; ... BENEFIT Study Grp,; + view all (2007) Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. LANCET , 370 (9585) 389 - 397.

Kappos, L; Gold, R; Miller, D; MacManus, DG; Havrdova, E; Limmroth, V; ... O'Neill, G; + view all (2007) Safety and tolerability results of a phase 2b extension study of the novel oral fumarate BG00012 for the treatment of relapsing-remitting multiple sclerosis. In: NEUROLOGY. (pp. A276 - A277). LIPPINCOTT WILLIAMS & WILKINS

Kasti, M; Sajic, M; Smith, KJ; (2007) Evidence for hypoxia-like conditions in vivo within the lesions of two experimental models of multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S257 - S258). SAGE PUBLICATIONS LTD

Khaleeli, Z; Cercignani, M; Audoin, B; Ciccarelli, O; Miller, DH; Thompson, AJ; (2007) Localised grey matter magnetisation transfer ratio changes contribute to disability in primary progressive multiple sclerosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1025 - 1026). B M J PUBLISHING GROUP

Khaleeli, Z; Cereignani, M; Audoin, B; Ciccarelli, O; Miller, DH; Thompson, AJ; (2007) Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. NEUROIMAGE , 37 (1) 253 - 261. 10.1016/j.neuroimage.2007.04.056.

Khaleeli, Z; Sastre-Garriga, J; Ciccarelli, O; Miller, DH; Thompson, AJ; (2007) Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J NEUROL NEUROSUR PS , 78 (10) 1076 - 1082. 10.1136/jnnp.2006.107565. Gold open access

Krumbholz, M; Theil, D; Steinmeyer, F; Cepok, S; Hemmer, B; Hofbauer, M; ... Meinl, E; + view all (2007) CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. J NEUROIMMUNOL , 190 (1-2) 72 - 79. 10.1016/j.jneuroim.2007.07.024.

Kuhle, J; Pohl, C; Mehling, M; Edan, G; Freedman, MS; Hartung, H; ... Sandbrink, R; + view all (2007) Lack of association between antimyelin antibodies and progression to multiple sclerosis. NEW ENGL J MED , 356 (4) 371 - 378.

M

Manfredonia, F; Ciccarelli, O; Khaleeli, Z; Tozer, DJ; Sastre-Garriga, J; Miller, DH; Thompson, AJ; (2007) Normal-appearing brain T1 relaxation time predicts disability in early primary progressive multiple sclerosis. ARCH NEUROL-CHICAGO , 64 (3) 411 - 415.

Marik, C; Felts, PA; Bauer, J; Lassmann, H; Smith, KJ; (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain , 130 (11) 2800 - 2815.

Miller, D; (2007) In memoriam - Professor Ian McDonald 1933-2006. J NEUROL , 254 (1) 129 - 129.

Miller, D; (2007) In memoriam professor John Newsom-Davis 1932-2007. J NEUROL , 254 (10) 1317 - 1317. 10.1007/s00415-007-0749-7.

Miller, D; (2007) In memoriam: Professor John Newsom-Davis 1932-2007. Journal of Neurology , 254 (10) 1317 - 1317.

Miller, D; (2007) Multiple sclerosis: new insights and therapeutic progress. LANCET NEUROL , 6 (1) 5 - 6.

Miller, D; (2007) Multiple sclerosis: new insights and therapeutic progress. Lancet Neurol , 6 (1) 5 - 6. 10.1016/S1474-4422(06)70660-3.

Miller, DH; (2007) Proof-of-concept trials of neuroprotection in MS: design and outcome markers. In: MULTIPLE SCLEROSIS. (pp. S18 - S19). SAGE PUBLICATIONS LTD

Miller, DH; Leary, SM; (2007) Primary-progressive multiple sclerosis. LANCET NEUROL , 6 (10) 903 - 912.

Miller, DH; MacManus, D; Thompson, AJ; Kappos, L; Barkhof, F; Polman, CH; ... Barker, GJ; + view all (2007) Slowing of cerebral atrophy after year 1 in a placebo-controlled trial of interferon beta 1b in secondary progressive multiple sclerosis. In: MULTIPLE SCLEROSIS. (pp. S49 - S49). SAGE PUBLICATIONS LTD

Miller, DH; Soon, D; Fernando, KT; MacManus, DG; Barker, GJ; Yousry, TA; ... Sandrock, AW; + view all (2007) MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. NEUROLOGY , 68 (17) 1390 - 1401.

O

O'Connor, P; Goodman, A; Kappos, L; Lublin, F; Miller, D; Polman, C; ... Panzana, M; + view all (2007) Safety of natalizumab upon re-dosing: preliminary results from the STRATA study. In: MULTIPLE SCLEROSIS. (pp. S168 - S169). SAGE PUBLICATIONS LTD

O'Regan, S; Meunier, FM; Newcombe, J; (2007) Choline transporter-like proteins in normal human CNS and multiple sclerosis lesions. NEURON GLIA BIOL , 2 S91 - S92.

P

Parkes, HG; Denham, M; Schmierer, K; (2007) High-resolution 1H NMR spectroscopy of multiple sclerosis brain. In: MULTIPLE SCLEROSIS. (pp. S251 - S252). SAGE PUBLICATIONS LTD

Pocock, JM; (2007) Metabotropic glutamate receptors on microglia; switching off toxicity. In: (Proceedings) 21st Biennial Meeting of the International Society for Neurochemistry and the 38th Annual Meeting of the American Society for Neurochemistry. (pp. S29A - ?). Journal of Neurochemistry

Pocock, JM; (2007) Microglial activation in neurodegenerative and neuroinflammatory disease: Control by neurotransmitter receptors. In: JOURNAL OF NEUROCHEMISTRY. (pp. 11 - 11). BLACKWELL PUBLISHING

Pocock, JM; Kettenmann, H; (2007) Neurotransmitter receptors on microglia. TRENDS NEUROSCI , 30 (10) 527 - 535. 10.1016/j.tins.2007.07.007.

Pocock, JM; Pinteaux-Jones, F; Fry, VA; Baker, D; Heales, SJ; (2007) Metabotropic glutamate receptors on microglia: Switching off toxicity. In: JOURNAL OF NEUROCHEMISTRY. (pp. 239 - 239). BLACKWELL PUBLISHING

Powell, HWR; Parker, GJM; Alexander, DC; Symms, MR; Boulby, PA; Wheeler-Kingshott, CAM; ... Duncan, JS; + view all (2007) Abnormalities of language networks in temporal lobe epilepsy. NEUROIMAGE , 36 (1) 209 - 221. 10.1016/j.neuroimage.2007.02.028.

Powell, HWR; Parker, GJM; Alexander, DC; Symms, MR; Wheeler-Kingshott, CAM; Boulby, PA; ... Duncan, JS; + view all (2007) Abnormalities of language networks in temporal lobe epilepsy. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 215 - 215). B M J PUBLISHING GROUP

R

Rashid, W; Chard, DT; Miller, DH; (2007) Atrophy. In: Filippi, M and Rovaris, M and Comi, G, (eds.) UNSPECIFIED (23 - 35). SPRINGER-VERLAG ITALIA

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Thompson, AJ; Miller, DH; (2007) Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study. MULT SCLER , 13 (2) 178 - 185. 10.1177/1352458506070758.

Ridha, BH; Symms, MR; Tozer, DJ; Stockton, KC; Frost, C; Siddique, MM; ... Tofts, PS; + view all (2007) Magnetization transfer ratio in Alzheimer disease: Comparison with volumetric measurements. AM J NEURORADIOL , 28 (5) 965 - 970.

Ridha, BH; Tozer, DJ; Symms, MR; Stockton, KC; Lewis, EB; Siddique, MM; ... Tofts, PS; + view all (2007) Quantitative magnetization transfer imaging in Alzheimer disease. RADIOLOGY , 244 (3) 832 - 837. 10.1148/radiol.2443061128.

Rudick, RA; Miller, D; Hass, S; Hutchinson, M; Calabresi, PA; Confavreux, C; ... SENTINEL Investigators,; + view all (2007) Health-related quality of life in multiple sclerosis: Effects of Natalizumab. ANN NEUROL , 62 (4) 335 - 346. 10.1002/ana.21163.

S

Sahai, A; Khan, MS; Gregson, N; Smith, K; Dasgupta, P; GKT, BSG; (2007) Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going. Nature Clinical Practice Urology , 4 (7) 379 - 386.

Saikali, P; Antel, JP; Newcombe, J; Chen, ZH; Freedman, M; Blain, M; ... Arbour, N; + view all (2007) NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J NEUROSCI , 27 (5) 1220 - 1228. 10.1523/JNEUROSCI.4402-06.2007.

Schmierer, K; Tozer, DJ; Scaravilli, F; Altmann, DR; Barker, GJ; Tofts, PS; Miller, DH; (2007) Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J MAGN RESON IMAGING , 26 (1) 41 - 51. 10.1002/jmri.20984. Gold open access

Schmierer, K; Wheeler-Kingshott, CAM; Boulby, PA; Scaravilli, F; Altmann, DR; Barker, GJ; ... Miller, DH; + view all (2007) Diffusion tensor imaging of post mortem multiple sclerosis brain. NEUROIMAGE , 35 (2) 467 - 477. 10.1016/j.neuroimage.2006.12.010. Gold open access

Schmierer, K.; Wheeler-Kingshott, C.; Boulby, P.A.; Scaravilli, F.; Altmann, D.R.; Barker, G.J.; ... Miller, D.H.; + view all (2007) Diffusion tensor imaging of post mortem multiple sclerosis brain. NeuroImage , 35 (2) pp. 467-477. 10.1016/j.neuroimage.2006.12.010.

Sevastou, IG; Pinteaux-Jones, F; Hooper, C; East, E; Fry, VHA; Pocock, JM; (2007) Microglial ROCK and Rho in MS. In: (Proceedings) Society for Neuroscience Annual Meeting. (pp. 804.10 - ?). Society for Neuroscience

Smith, KJ; (2007) Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy. Brain Pathol , 17 (2) 230 - 242. 10.1111/j.1750-3639.2007.00066.x.

So, PW; Parkes, HG; Bell, JD; (2007) Application of magnetic resonance methods to studies of gene therapy. PROG NUCL MAG RES SP , 51 (1) 49 - 62. 10.1016/j.pnmrs.2007.02.001.

Soon, D; Altmann, DR; Fernando, KTM; Giovannoni, G; Barkhof, F; Polman, CH; ... Miller, DH; + view all (2007) A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis. J NEUROL , 254 (3) 306 - 314. 10.1007/s00415-006-0356-z.

Soon, D; Tozer, DJ; Altmann, DR; Tofts, PS; Miller, DH; (2007) Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. MULT SCLER , 13 (7) 884 - 894. 10.1177/1352458507076970.

Summers, M; Drapier, S; Fisniku, L; Cercignani, M; Cipolotti, L; Miller, D; Ron, MA; (2007) A voxel-based analysis of diffusion tensor images and cognition in relapsing-remitting multiple sclerosis. In: JOURNAL OF NEUROLOGY. (pp. 137 - 137). DR DIETRICH STEINKOPFF VERLAG

Swanton, J.K.; Rovira, A.; Tintore, M.; Altmann, D.R.; Barkhof, F.; Filippi, M.; ... Miller, D.H.; + view all (2007) MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. The Lancet Neurology , 6 (8) pp. 677-686. 10.1016/S1474-4422(07)70176-X.

Swanton, JK; Rovira, A; Tintore, M; Altmann, DR; Barkhof, F; Filippi, M; ... Miller, DH; + view all (2007) MR1 criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. LANCET NEUROL , 6 (8) 677 - 686. 10.1016/S1474-4422(07)70176-X.

T

Tofts, PS; Benton, CE; Weil, RS; Tozer, DJ; Altmann, DR; Jager, HR; ... Rees, JH; + view all (2007) Quantitative analysis of whole-tumor Gd enhancement histograms predicts malignant transformation in low-grade gliomas. J MAGN RESON IMAGING , 25 (1) 208 - 214. 10.1002/jmri.20800.

Tozer, DJ; Jager, HR; Danchaivijitr, N; Benton, CE; Tofts, PS; Rees, JH; Waldman, AD; (2007) Apparent diffusion coefficient histograms may predict low-grade glioma subtype. NMR BIOMED , 20 (1) 49 - 57. 10.1002/nbm.1091.

Trip, S; Schlottmann, PG; Jones, S; Li, WY; Thompson, A; Plont, GT; Miller, DH; (2007) Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis. MULT SCLER , 13 (7) 875 - 879. 10.1177/1352458507076952.

Y

Yogarajah, M; Powell, HWR; Parker, GJM; Alexander, DC; Symms, MR; Boulby, P; ... Duncan, JS; + view all (2007) Atrophy of medial temporal lobe connections in unilateral temporal lobe epilepsy: A tractography based study. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1033 - 1033). B M J PUBLISHING GROUP

Yogarajah, M; Powell, HWR; Parker, GJM; Alexander, DC; Symms, MR; Boulby, P; ... Duncan, JS; + view all (2007) Reorganisation of medial temporal lobe connections in unilateral temporal lobe epilepsy. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 784 - 784). B M J PUBLISHING GROUP

Yogarajah, M; Powell, R; Parker, G; Alexander, D; Symms, M; Boulby, P; ... Duncan, J; + view all (2007) Tractography of the parahippocampal gyrus and material specific memory impairment in unilateral temporal lobe epilepsy. In: EPILEPSIA. (pp. 135 - 135). BLACKWELL PUBLISHING

This list was generated on Sun Oct 26 03:46:09 2014 GMT.